Rectal Microbes Influence Effectiveness of HIV Vaccine

December 13, 2019
Microbes living in the rectum could make a difference to the effectiveness of experimental HIV vaccines, according to research led by Smita Iyer, assistant professor at the UC Davis Center for Immunology and Infectious Diseases and School of Veterinary Medicine. 

Mapping the Pathway to Gut Health in HIV and SIV Infections

November 20, 2019
Katti (Horng) Crakes, doctoral student in the schools of Medicine and Veterinary Medicine at UC Davis, served as first author on a UC Davis research study that found that the damaged gut lining (known as leaky gut) in monkeys infected with chronic simian immunodeficiency virus (SIV), an HIV-like virus, was rapidly repaired within five hours of receiving Lactobacillus plantarum bacteria. The outcome lends hope that leaky gut, a common condition among HIV patients, could be effectively treated in the future.

New Approach for Canine Epilepsy

October 30, 2019
Researchers and clinicians at UC Davis veterinary hospital are evaluating a novel technique to better understand and treat canine epilepsy.

UC Davis Advances Regenerative Cures

August 08, 2018
Since 2012, the Veterinary Institute for Regenerative Cures (VIRC) at the UC Davis School of Veterinary Medicine (SVM) has been committed to transforming the SVM into a national leader for veterinary regenerative medicine. VIRC has established laboratory techniques and animal models that have been used to study regenerative therapies for veterinary and human medicine. It has characterized equine, canine and feline stem cells isolated from different tissues with a focus on adult-derived mesenchymal stem cells.

Building Research Teams of the Future

July 06, 2018

The latest newsletter from the UC Davis Clinical and Translational Science Center highlights collaborations among researchers from human and veterinary medicine. Articles include how clinical trials with animal patients speeds translation to improved care for people, partnerships in human-animal eye research, and new hope from novel canine cancer therapy treatments and feline stem cell therapy for an oral inflammatory disease. Read more

Stem Cell Therapy: Helping Cats with Unresponsive FCGS

June 18, 2018

A rescued domestic shorthaired cat named “Lily” has helped prove the efficacy of a game-changing treatment for feline chronic gingivostomatitis (FCGS), or stomatitis for short. The lucky feline, adopted by Cyndi Luke of Davis, California, had been treated unsuccessfully for three years when she was recruited to take part in a stem-cell therapy trial testing a cutting-edge procedure for the painful oral condition.